Navigation Links
Lifeline Biotechnologies' First Warning Systems
Date:7/19/2012

RENO, Nev., July 19, 2012 /PRNewswire/ -- Lifeline Biotechnologies, Inc., (PINKSHEETS: LLBO) announces its primary affiliate and investment, First Warning Systems, Inc., has updated its website with a dynamic video.  The video demonstrates the Company's core technology that identifies breast tumors at the earliest stage.  Many of these tumors could develop into threatening diseases.  The early identification of these tumors is many years ahead of other process capabilities (First Warning's website, firstwarningsystems.com).

Jim Holmes, Lifeline's CEO said, "This video is one of our best summaries of the First Warning Systems' capabilities and explains how and when tumors occur and how doubling times impact their development to a critical stage.  These tumors are breast tissue abnormalities, some of which could develop into threatening diseases such as breast cancers.  We urge all to visit the First Warning website and view this descriptive and informative video." 

About Lifeline Biotechnologies Lifeline Biotechnologies, Inc. (PINKSHEETS: LLBO) founded in 1994 is based in Reno, NV. The Company has licensed its primary affiliate, First Warning Systems, Inc.  The license covers Lifeline's core, patented technology, and conveys the manufacturing and marketing rights to First Warning.  The device and process identifies, at very early stages of development, breast tissue abnormalities some of which are cancerous or pre-cancer.  Patents have been issued based on the results of three clinical trials involving over 650 participants.  The developmental clinical trials confirmed the First Warning Systems' "Proof of Concept," and its capabilities.  www.lbti.com.

About First Warning Systems First Warning Systems (FWS) founded in 2008, based in Reno, NV is an affiliate of Lifeline Biotechnologies, Inc (LLBO).  FWS holds the exclusive development, marketing and manufacturing license to commercialize LLBO's intellectual property for the FWS product line.  The product line is a device and process for early detection of breast tissue abnormalities that provide the opportunity to deal with health risk assessment and management.  Three clinical trials with over 650 participants have achieved superior outcomes when compared to other detection/diagnostic protocols. FWS is planning a final, limited clinical trial followed by a FDA 510(k) device classification submission.  The 510(k) clears the FWS for commercialization.  www.firstwarningsystems.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtaining financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

For more information, contact: Jim Holmes, CEO 775-852-3222 Email: lholmes@lbti.com


'/>"/>
SOURCE Lifeline Biotechnologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. Thoratec Schedules First Quarter Conference Call, Webcast
4. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
5. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
6. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
7. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
8. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
9. Insmed to Host 2012 First Quarter Earnings Conference Call
10. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
11. Henry Schein to Webcast First Quarter 2012 Conference Call Tuesday, May 8, at 10:00 a.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... CAMBRIDGE, Mass. , March 23, 2017 ... the enrollment of its first patient in a Phase ... an antibody-directed nanotherapeutic (ADN) that encapsulates a novel taxane ... suggest is overexpressed in 50-100% of many major tumor ... cancers. "The initiation of this study is ...
(Date:3/23/2017)... March 23, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" ... specialty pharmaceutical company, is pleased to announce that ... approval from the U.S. Food and Drug Administration ... ("ANDA") for tetrabenazine tablets in the 12.5 mg ... is a generic equivalent of the branded product ...
(Date:3/23/2017)...   Casetabs , the pioneer surgery coordination application, ... the iPhone. With this new release, Casetabs is further ... physician offices, ambulatory surgery centers (ASCs) and hospitals. The ... even faster, more reliable access to case information. ... connect care teams so that surgeries can be coordinated ...
Breaking Medicine Technology:
(Date:3/23/2017)... Raleigh, NC (PRWEB) , ... March 23, 2017 , ... ... the ride). Life is serious so build on a solid foundation. As experts ... high priority vital information that is coming soon. Inflownomics deliver ripe, fresh, clean & ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... herbal-based and non-steroidal skincare products, was awarded as winners of American Dreams & ... This competition was hosted jointly by HSN and Good Housekeeping. , Steven ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... software solution, iCode Assurance, at HCCA’s 21st annual Compliance Institute on March 26-28 ... coding audit process for all medical chart types with a comprehensive set of ...
(Date:3/23/2017)... , ... March 23, 2017 , ... “My Journey Through ... experience with an infinitely more profound faith of God’s promise of Heaven for His ... Jr., who spends each day with his wife, three children and six grandchildren living ...
(Date:3/23/2017)... ... , ... “More Corruption”: a simple and strong explanation of the God’s love. “More Corruption” ... Heaven was asked by God to write a book about Him. , She says, “I’m ... kept my commitment to the Lord God. They have not walked in my shoes and ...
Breaking Medicine News(10 mins):